Identification and endovascular treatment of a rare deep circumflex iliac artery-L3 lumbar artery anastomosis causing type II aortic aneurysm endoleak Authors: Jacob Fryer, Michael Shonnard, Ronald Blasini, James Mega Published: 2026 ABSTRACT Type II endoleaks are the most common complication after endovascular aneurysm repair typically arising from mesenteric and lumbar inflow vessels, whereas alternative collateral sources are less frequently recognized. We report a case of a deep circumflex iliac artery-mediated collateral causing persistent sac perfusion, identified on preprocedural imaging and confirmed angiographically. Targeted coil embolization resulted in occlusion of the culprit pathway with resolution of sac opacification. Follow-up imaging demonstrated a separate endoleak from a distinct collateral source without sac enlargement, consistent with flow redistribution. These findings highlight the importance of evaluating atypical collateral pathways. Type II endoleaks represent the most common subtype following endovascular aneurysm repair (EVAR),1 caused by retrograde collateral perfusion of the aneurysm sac, most frequently via the inferior mesenteric and lumbar arteries.2 Although anastomotic connections between the deep circumflex iliac artery (DCIA) and lumbar arteries are well described anatomically,3,4 their role as a source of type II endoleaks has rarely been reported.5, 6, 7, 8, 9 Consequently, the DCIA is not routinely interrogated during standard angiographic evaluation, which may contribute to under-recognition. We present a case of a DCIA-lumbar artery collateral resulting in a type II endoleak that was identified on cross-sectional imaging before intervention and treated with targeted embolization. This case highlights a rare etiology of endoleak and the feasibility of preprocedural identification of atypical collateral pathways while also elucidating their clinical significance. Case An 80-year-old man with metastatic bladder cancer was found to have an infrarenal abdominal aortic aneurysm (AAA) measuring 4.1 cm on computed tomography (CT) urogram in December 2017. Serial imaging demonstrated enlargement to 5.6 cm on CT angiography (CTA) in July 2023, meeting the Society for Vascular Surgery criteria for repair.2 The patient underwent EVAR in September 2023 using a GORE Excluder Conformable AAA endoprosthesis (W. L. Gore & Associates). Postprocedural CTA at 1 month reported a decrease in aneurysm sac size to 5.3 cm without evidence of endoleak. Follow-up imaging with CTA and duplex ultrasound study was performed across multiple institutions because of patient-specific circumstances, supplemented by oncologic surveillance CT. A CTA obtained in July 2024 reported a stable sac size with a new mid-posterior sac contrast blush, consistent with a type II endoleak, without evidence of type I or type III endoleak. A CT urogram in August 2024 noted sac enlargement to 5.6 cm with a persistent mid-posterior endoleak. Duplex ultrasound study in September 2024 noted a sac size of 4.8 cm without a detectable endoleak. Follow-up ultrasound study in September 2025 identified sac enlargement to 5.3 cm with evidence of endoleak, whereas a contemporaneous oncologic staging CT demonstrated a size of 5.8 cm with a persistent mid-posterior endoleak. The patient was referred for endoleak repair in accordance with Society for Vascular Surgery guidelines, which recommend intervention for sac expansion of ≥0.5 cm.1,10 Preprocedural review of cross-sectional imaging demonstrated an asymmetrically prominent vessel arising from the left external iliac artery, coursing along the lateral abdominal wall and posterior peritoneum toward the region of the contrast blush, suspicious for a DCIA-lumbar collateral (Fig 1).Fig 1Sequential computed tomography images demonstrating a prominent left deep circumflex iliac artery-lumbar collateral pathway. The vessel originates from the lateral aspect of the external iliac artery (top left, red arrow), courses laterally along the iliac crest within the plane between the transversus ado minis and internal oblique muscles (top right, red arrow), and then continues posteriorly along the inner iliac crest. The ascending branch extends medially within the fascial plane, deep to the transversus abdominis and anterior to the quadratus lumborum (bottom left, red arrows), where it forms collateral communication with the lumbar arterial branches. This collateral then courses posterior to the psoas major muscle and supplies the aneurysm sac (bottom right, red arrows). Sequential computed tomography images demonstrating a prominent left deep circumflex iliac artery-lumbar collateral pathway. The vessel originates from the lateral aspect of the external iliac artery (top left, red arrow), courses laterally along the iliac crest within the plane between the transversus ado minis and internal oblique muscles (top right, red arrow), and then continues posteriorly along the inner iliac crest. The ascending branch extends medially within the fascial plane, deep to the transversus abdominis and anterior to the quadratus lumborum (bottom left, red arrows), where it forms collateral communication with the lumbar arterial branches. This collateral then courses posterior to the psoas major muscle and supplies the aneurysm sac (bottom right, red arrows). Fluoroscopic angiography in November 2025 confirmed retrograde flow from the left DCIA into the ipsilateral L3 lumbar artery, with aneurysm sac opacification, consistent with a type II endoleak (Fig 2). Selective catheterization of the lumbar artery was achieved via the DCIA, and embolization was performed using absorbable gelatin sponge (Gelfoam; Pfizer Inc.) and a fibered coil (Merit Medical Systems). Completion angiography demonstrated elimination of flow into the aneurysm sac (Fig 3).Fig 2Preintervention digital subtraction angiography demonstrates the left deep circumflex iliac artery (gray arrows) with collateral communication to the left L3 lumbar artery. Contrast opacification of the aneurysm sac (black arrow) via this pathway is consistent with a type II endoleak. Previously placed coils are incidentally noted within the left internal iliac artery (white arrow), placed during previous endovascular aneurysm repair.Fig 3Postintervention digital subtraction angiography demonstrating the deep circumflex iliac artery-lumbar collateral (red arrows) with resolution of the aneurysm sac contrast blush status following embolization using absorbable gelatin sponge and endovascular coil (black arrow). Preintervention digital subtraction angiography demonstrates the left deep circumflex iliac artery (gray arrows) with collateral communication to the left L3 lumbar artery. Contrast opacification of the aneurysm sac (black arrow) via this pathway is consistent with a type II endoleak. Previously placed coils are incidentally noted within the left internal iliac artery (white arrow), placed during previous endovascular aneurysm repair. Postintervention digital subtraction angiography demonstrating the deep circumflex iliac artery-lumbar collateral (red arrows) with resolution of the aneurysm sac contrast blush status following embolization using absorbable gelatin sponge and endovascular coil (black arrow). Follow-up CTA 3 months after embolization demonstrated a stable aneurysm sac size of 5.8 cm with resolution of the mid-posterior contrast blush. However, a new right posterolateral contrast blush was identified adjacent to prominent iliolumbar collaterals, favored to represent a distinct type II endoleak (Fig 4). No type I or type III endoleak was identified.Fig 4Side-by-side comparison of the most recent preintervention computed tomography (CT) in portal venous phase (left image) and the most recent postintervention delayed phase CT angiography (CTA) (right image). The preintervention study demonstrates a prominent mid-posterior aneurysm sac contrast blush (red arrow). On postintervention imaging, there is interval resolution of the mid-posterior blush with development of a new right posterolateral contrast blush (red and black arrow). An endovascular coil is noted within the treated left posterolateral deep circumflex iliac artery-lumbar collateral (right image). Side-by-side comparison of the most recent preintervention computed tomography (CT) in portal venous phase (left image) and the most recent postintervention delayed phase CT angiography (CTA) (right image). The preintervention study demonstrates a prominent mid-posterior aneurysm sac contrast blush (red arrow). On postintervention imaging, there is interval resolution of the mid-posterior blush with development of a new right posterolateral contrast blush (red and black arrow). An endovascular coil is noted within the treated left posterolateral deep circumflex iliac artery-lumbar collateral (right image). The spatially distinct location of contrast blush supports collateral redistribution rather than incomplete embolization. Given stable aneurysm sac size, the patient is undergoing surveillance at 6-month intervals for 2 years followed by annual imaging, with reintervention if significant sac enlargement occurs. Written informed consent was obtained from the patient for publication of this case report and the accompanying images. A summarized timeline of the case is provided in the Table.TableTimelineMonths yearStudyReported aneurysm sac size (cm)Endoleak statusDecember 2017CT urogram4.1Incidental finding of infrarenal AAAJuly 2023CTA5.6–September 2023EVAR performed––October 2023CTA5.3No endoleakJuly 2024CTA5.3New mid-posterior sac endoleak, likely type IIAugust 2024CT urogram5.6Persistent mid-posterior endoleak, likely type IISeptember 2024Duplex aortic ultrasound study4.8No endoleak identifiedSeptember 2025Duplex aortic ultrasound study5.3Endoleak present, although location not precisely demonstratedSeptember 2025CT chest/abdomen/pelvis5.8Persistent mid-posterior endoleak, likely type IIDecember 2025Type II endoleak repair–Angiographic exclusion of aneurysm sac contrast blush via the DCIA–lumbar collateral pathwayJanuary 2026CTA5.8Resolved mid-posterior type II endoleak; new right posterolateral endoleak, likely type IIAAA, Abdominal aortic aneurysm; CT, computed tomography; CTA, computed tomography angiography; DCIA, deep circumflex iliac artery; EVAR, endovascular aneurysm repair. TableTimelineMonths yearStudyReported aneurysm sac size (cm)Endoleak statusDecember 2017CT urogram4.1Incidental finding of infrarenal AAAJuly 2023CTA5.6–September 2023EVAR performed––October 2023CTA5.3No endoleakJuly 2024CTA5.3New mid-posterior sac endoleak, likely type IIAugust 2024CT urogram5.6Persistent mid-posterior endoleak, likely type IISeptember 2024Duplex aortic ultrasound study4.8No endoleak identifiedSeptember 2025Duplex aortic ultrasound study5.3Endoleak present, although location not precisely demonstratedSeptember 2025CT chest/abdomen/pelvis5.8Persistent mid-posterior endoleak, likely type IIDecember 2025Type II endoleak repair–Angiographic exclusion of aneurysm sac contrast blush via the DCIA–lumbar collateral pathwayJanuary 2026CTA5.8Resolved mid-posterior type II endoleak; new right posterolateral endoleak, likely type IIAAA, Abdominal aortic aneurysm; CT, computed tomography; CTA, computed tomography angiography; DCIA, deep circumflex iliac artery; EVAR, endovascular aneurysm repair. Timeline AAA, Abdominal aortic aneurysm; CT, computed tomography; CTA, computed tomography angiography; DCIA, deep circumflex iliac artery; EVAR, endovascular aneurysm repair. Discussion This case highlights a rare source of type II endoleak arising from a DCIA-lumbar artery collateral. Existing literature is limited to small case series and reports that primarily demonstrate the technical feasibility of DCIA cannulation and embolization. Clinical outcomes remain variable, including persistent endoleaks and the need for repeat interventions.5, 6, 7, 8, 9 The present case reaffirms the technical utility of targeted DCIA-mediated embolization, as evidenced by angiographic exclusion and resolution of the mid-posterior sac blush. The subsequent development of a new type II endoleak from a separate collateral source is consistent with the well-described phenomenon of persistence or recurrence following embolization, with recurrence rates as high as 60%,11 likely driven by collateral redundancy.10 This likely reflects flow redistribution rather than technical treatment failure, particularly given stable aneurysm sac size. Unlike previous reports, this case demonstrates the value of preprocedural cross-sectional imaging in identifying rare collateral sources of endoleak. Although DCIA involvement has traditionally been recognized only during angiography, preprocedural identification in this case enabled targeted catheterization via the external iliac artery. Awareness of atypical collateral pathways may improve procedural planning and reduce complexity, fluoroscopy time, and contrast use. These findings raise the question of prophylactic DCIA embolization. Retrospective review confirmed the vessel was present before EVAR and may have been amenable to pretreatment. Prophylactic embolization of commonly implicated vessels such as the inferior mesenteric and lumbar arteries reduces type II endoleak incidence in the selected patients.12,13 Whether similar strategies may be applicable to atypical collateral pathways warrants further investigation. This study is limited by heterogeneity in imaging acquisition and interpretation across institutions, contributing to measurement variability. Retrospective standardized measurements demonstrated 0.2 cm sac growth before intervention, compared with reported values of 0.5 cm, consistent with known AAA measurement variability. For example, CT-based interobserver and intraobserver variability averages approximately 0.5 cm and 0.3 cm, respectively.14,15 Ultrasound study measurements may exhibit wider limits of agreement, reaching up to approximately 1 cm.16 Intermodality differences further compound this variability, with the American College of Radiology reporting average discrepancies of approximately 0.1 to 0.3 cm between CT and ultrasound study.17,18 These differences likely reflect inconsistent use of centerline-based, outer wall-to-outer wall measurements and suboptimal alignment in tortuous anatomy, which requires three-dimensional reformatting or image plane manipulation.19, 20, 21 Similar limitations are evident throughout the existing literature. Notably, the index report of a DCIA-mediated type II endoleak did not clearly demonstrate aneurysm sac expansion before intervention, underscoring variability in measurements and treatment thresholds.5 Although other DCIA endoleak cases have demonstrated ≥0.5 cm sac growth before intervention,6, 7, 8, 9 the measurement methodology is poorly described, limiting direct comparison. More broadly, the clinical benefit of treating type II endoleaks remains uncertain, as current evidence has not demonstrated consistent improvements in survival or aneurysm-related outcomes following reintervention, and recurrence rates remain high.10,22, 23, 24, 25 Overall, these limitations suggest that although the technical and diagnostic features of DCIA-mediated collaterals have become increasingly recognized, their clinical significance remains uncertain. Conclusions This case highlights a rare DCIA-lumbar collateral causing type II endoleak and demonstrates the value of preprocedural imaging in identifying the collateral pathways. Targeted embolization excluded the culprit vessel, confirming technical success. A distinct endoleak with stable aneurysm sac size at 3-month follow-up indicates collateral redistribution rather than treatment failure. Further study is needed to define the clinical significance and management of atypical collateral pathways. Key takeaways 1.Preprocedural cross-sectional imaging should be evaluated for atypical collateral pathways, including the deep circumflex iliac artery, to facilitate targeted intervention planning.2.Prophylactic embolization of atypical collateral pathways such as the deep circumflex iliac artery warrants further investigation.3.Standardized measurement protocols should be universally adopted for aneurysm surveillance to improve interpretation of type II endoleak outcomes. 1.Preprocedural cross-sectional imaging should be evaluated for atypical collateral pathways, including the deep circumflex iliac artery, to facilitate targeted intervention planning. Preprocedural cross-sectional imaging should be evaluated for atypical collateral pathways, including the deep circumflex iliac artery, to facilitate targeted intervention planning. 2.Prophylactic embolization of atypical collateral pathways such as the deep circumflex iliac artery warrants further investigation. Prophylactic embolization of atypical collateral pathways such as the deep circumflex iliac artery warrants further investigation. 3.Standardized measurement protocols should be universally adopted for aneurysm surveillance to improve interpretation of type II endoleak outcomes. Standardized measurement protocols should be universally adopted for aneurysm surveillance to improve interpretation of type II endoleak outcomes. Funding This work was funded by the 10.13039/100010196Tripler Army Medical Center General Medical Education Department, which had no involvement in the study design or collection, analysis, and interpretation of data. The views expressed in this case report are those of the authors and do not necessarily reflect the official policy or position of the Defense Health Agency, Department of Defense (DOD), nor the U.S. Government. Neither the Defense Health Agency, any other component of the DOD nor the U.S. Government has approved, endorsed, or authorized this work product. Declaration of generative AI and AI-assisted technologies in the writing process During the preparation of this work, the authors used ChatGPT 5.3 to improve readability and language and OpenEvidence to facilitate literature review. After using these tools, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. Disclosures None.